Medication info
Depentidine Tablet 10 mg (Rabeprazole)

Depentidine Tablet 10 mg (Rabeprazole)

Prescription medicationTablet
Ingredient · strength
Lafutidine›10mg / 1 tablet
Manufacturer / importer
Mothers Pharmaceutical Co., Ltd.
Appearance
White round film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 201804019 · Approved 2018.10.15 · Insurance code 622803300

Summary

Main use
Treatment of gastrointestinal disorders (ulcers, gastritis, etc.), preanesthetic medication, and combination therapy with antibiotics for Helicobacter pylori
Who uses it
Adults
Adult dosage
1. Short-term treatment of gastric ulcers: The usual dose of lafutidine is 10mg orally twice daily, in the morning and before bedtime. In clinical trials in which treatment was given for up to 8 weeks, most ulcers healed within 8 weeks; however, the healing period may occasionally vary from patient to patient. 2. Short-term treatment of duodenal ulcers: The usual dose of lafutidine is 10mg orally twice daily, in the morning and before bedtime. In clinical trials in which treatment was given for up to 6 weeks, most ulcers healed within 6 weeks; however, the healing period may occasionally vary from patient to patient. 3. Improvement of gastric mucosal lesions in acute and chronic gastritis: The usual dose of lafutidine is 10mg orally once daily before bedtime. In clinical trials in which treatment was given for up to 2 weeks, most lesions healed within 2 weeks; however, the healing period may occasionally vary from patient to patient. 4. Combination therapy with antibiotics for patients with peptic ulcers infected with Helicobacter pylori: Administer lafutidine 20mg, clarithromycin 500mg, and amoxicillin 1000mg twice daily for 7 or 14 days. 5. Premedication before anesthesia: The usual dose of lafutidine is 10mg per dose, administered orally twice (before bedtime on the day before surgery and 2 hours before anesthesia on the day of surgery). 6. Treatment of reflux esophagitis: Administer lafutidine 10mg per dose orally twice daily.

Ingredients

Manufacturer
Mothers Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of gastrointestinal disorders (ulcers, gastritis, etc.), preanesthetic medication, and combination therapy with antibiotics for Helicobacter pylori

  • Gastric ulcer
  • duodenal ulcer
  • acute gastritis
  • chronic gastritis
  • gastric mucosal lesions
  • peptic ulcer
  • gastroesophageal reflux disease
View approved original text

This medication is used for the treatment of gastric ulcers and duodenal ulcers. It also helps improve gastric mucosal damage caused by acute and chronic gastritis, and it assists in the treatment of peptic ulcer patients with Helicobacter pylori infection when combined with antibiotics. It is also used for pre-anesthesia medication before surgery and is effective in treating gastroesophageal reflux disease. Thus, it is widely used in various gastrointestinal-related diseases.

Dosage and Administration

Adult dosage

1. Short-term treatment of gastric ulcers: The usual dose of lafutidine is 10mg orally twice daily, in the morning and before bedtime. In clinical trials in which treatment was given for up to 8 weeks, most ulcers healed within 8 weeks; however, the healing period may occasionally vary from patient to patient. 2. Short-term treatment of duodenal ulcers: The usual dose of lafutidine is 10mg orally twice daily, in the morning and before bedtime. In clinical trials in which treatment was given for up to 6 weeks, most ulcers healed within 6 weeks; however, the healing period may occasionally vary from patient to patient. 3. Improvement of gastric mucosal lesions in acute and chronic gastritis: The usual dose of lafutidine is 10mg orally once daily before bedtime. In clinical trials in which treatment was given for up to 2 weeks, most lesions healed within 2 weeks; however, the healing period may occasionally vary from patient to patient. 4. Combination therapy with antibiotics for patients with peptic ulcers infected with Helicobacter pylori: Administer lafutidine 20mg, clarithromycin 500mg, and amoxicillin 1000mg twice daily for 7 or 14 days. 5. Premedication before anesthesia: The usual dose of lafutidine is 10mg per dose, administered orally twice (before bedtime on the day before surgery and 2 hours before anesthesia on the day of surgery). 6. Treatment of reflux esophagitis: Administer lafutidine 10mg per dose orally twice daily.

Precautions

This medicine should not be used by patients allergic to its components. Moreover, this product contains lactose, and should not be administered to patients with a genetic disorder that prevents lactose digestion. Patients with a history of drug allergies, liver or kidney dysfunction, those undergoing dialysis, and the elderly should use this medicine cautiously. While using this drug, serious allergic reactions such as anaphylaxis may occur, thus if symptoms such as pale face, hypotension, or difficulty breathing appear, the medicine must be discontinued immediately, and proper treatment should be sought. Liver function may be adversely affected, so if liver enzyme levels rise or jaundice symptoms appear, the medication should be discontinued and a doctor consulted. Serious side effects such as agranulocytosis or thrombocytopenia, which may cause a decrease in blood cell counts, can occur. If symptoms such as sore throat, malaise, or fever arise, the use of the medication should be stopped immediately. Additionally, various side effects such as rare skin rashes, seizures, or cardiac issues have been reported, and if any abnormal symptoms occur, consult a physician. Gastrointestinal issues may include constipation, diarrhea, nausea, vomiting, abdominal bloating, loss of appetite, while central nervous system issues may include headache, insomnia, drowsiness, dizziness. Elderly patients should be closely monitored with adjustments to dosage and administration schedule due to weakened bodily functions. Dialysis patients may have increased drug concentration in the blood, and therefore should start at low dosages with caution. Pregnant women should only use this medicine when deemed necessary by a doctor and nursing women are advised against using this medication as it may be excreted in breast milk. The safety for children has not been sufficiently established, therefore it should be used in children with caution. This medicine should be kept out of reach of children and stored in its original packaging to maintain quality. If symptoms suggestive of malignant tumors or suspected gastric cancer arise, detailed examinations should be mandated before using this medication, and the drug should be discontinued if malignancy is confirmed. During treatment, the condition of the disease should be carefully monitored and alternative treatment methods should be made if no effect is observed. Routine checks of liver function, kidney function, blood tests, etc., should be done, and immediate consultation with a physician is required if abnormalities are detected.

Side effects

  • Shock
  • anaphylaxis symptoms
  • facial pallor
  • hypotension
  • generalized rash
  • dyspnea
  • liver dysfunction
  • jaundice
  • agranulocytosis
  • pharyngitis
Show 83 more
  • general malaise
  • fever
  • thrombocytopenia
  • pancytopenia
  • aplastic anemia
  • seizures
  • interstitial nephritis
  • Stevens-Johnson syndrome
  • Liel syndrome
  • rhabdomyolysis
  • atrioventricular block
  • heart failure
  • constipation
  • diarrhea
  • hard stools
  • nausea
  • vomiting
  • abdominal distension
  • anorexia
  • headache
  • insomnia
  • drowsiness
  • reversible confusional state
  • hallucinations
  • consciousness disturbances
  • dizziness
  • chills
  • warmth sensation
  • facial flushing
  • leukocytosis
  • eosinophilia
  • leukopenia
  • erythrocytopenia
  • decreased hematocrit
  • elevated ALT
  • elevated AST
  • elevated Al-P
  • elevated γ-GTP
  • elevated T-Bil
  • elevated LDH
  • elevated TTT
  • abnormal urinary protein
  • elevated BUN
  • elevated serum uric acid
  • elevated Cl
  • delayed biological processes
  • elevated Na
  • decreased K
  • gynecomastia
  • edema
  • lethargy
  • glossitis
  • headache
  • chest pain
  • subdural hemorrhage
  • urticaria
  • skin rash
  • abdominal pain
  • dyspepsia
  • enteritis
  • gastric ulcer
  • erosive gastritis
  • duodenitis
  • bloating
  • nasopharyngitis
  • upper respiratory infection
  • bronchopneumonia
  • tinea
  • carotid artery stenosis
  • cough
  • oropharyngeal pain
  • oropharyngeal discomfort
  • productive cough
  • fatigue
  • chest pain
  • limb pain
  • arthralgia
  • cervical pain
  • pruritus
  • acne
  • contusions
  • insomnia
  • non-alcoholic fatty liver disease

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture. It is recommended to maintain a storage temperature between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

White round film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.